Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
复制标题
戊型肝炎病毒 (HEV) 人畜共患传播的管理:使用 HEV 239 疫苗免疫后保护兔子免受 HEV 挑战
DOI:
10.1371/journal.pone.0087600
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Zhuang H
中科院分区:
文献类型:
--
作者:
Liu P;Du Rj;Wang L;Han J;Liu L;Zhang Yl;Xia Jk;Lu Fm;Zhuang H
Hepatitis E virus (HEV) constitutes a significant health burden worldwide, with an estimated approximately 33% of the world’s population exposed to the pathogen. The recent licensed HEV 239 vaccine in China showed excellent protective efficacy against HEV of genotypes 1 and 4 in the general population and pregnant women. Because hepatitis E is a zoonosis, it is also necessary to ascertain whether this vaccine can serve to manage animal sources of human HEV infection. To test the efficacy of the HEV 239 vaccine in protecting animal reservoirs of HEV against HEV infection, twelve specific-pathogen-free (SPF) rabbits were divided randomly into two groups of 6 animals and inoculated intramuscularly with HEV 239 and placebo (PBS). All animals were challenged intravenously with swine HEV of genotype 4 or rabbit HEV seven weeks after the initial immunization. The course of infection was monitored for 10 weeks by serum ALT levels, duration of viremia and fecal virus excretion and HEV antibody responses. All rabbits immunized with HEV 239 developed high titers of anti-HEV and no signs of HEV infection were observed throughout the experiment, while rabbits inoculated with PBS developed viral hepatitis following challenge, with liver enzyme elevations, viremia, and fecal virus shedding. Our data indicated that the HEV 239 vaccine is highly immunogenic for rabbits and that it can completely protect rabbits against homologous and heterologous HEV infections. These findings could facilitate the prevention of food-borne sporadic HEV infection in both developing and industrialized countries.
登录
查看更多内容
影响因子:
11.8
作者:
Li TC;Chijiwa K;Sera N;Ishibashi T;Etoh Y;Shinohara Y;Kurata Y;Ishida M;Sakamoto S;Takeda N;Miyamura T
通讯作者:
Miyamura T
影响因子:
11.8
作者:
Liu P;Bu QN;Wang L;Han J;Du RJ;Lei YX;Ouyang YQ;Li J;Zhu YH;Lu FM;Zhuang H
通讯作者:
Zhuang H
影响因子:
3.2
作者:
Geng, Yansheng;Zhao, Chenyan;Wang, Youchun
通讯作者:
Wang, Youchun
影响因子:
9.4
作者:
Meng, XJ;Wiseman, B;Purcell, RH
通讯作者:
Purcell, RH
影响因子:
158.5
作者:
Kamar, Nassim;Selves, Janick;Rostaing, Lionel
通讯作者:
Rostaing, Lionel